Sevoflurane Decreases the Risk of Postoperative Delirium After Cerebral Hypoxemia During Surgery
NCT ID: NCT02133638
Last Updated: 2014-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
130 participants
INTERVENTIONAL
2014-05-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Sevoflurane, Propofol and Dexmedetomidine on Delirium & Neuroinflammation in Mechanically Ventilated Patients
NCT02394418
The Effect of Desflurane Versus Sevoflurane on Postoperative Recovery
NCT05331027
Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevorane in Adult Patients Required General Anesthesia for Surgery in Terms of Quality of Anesthesia and Its Influence on Cardiovascular System in Common Clinical Practice
NCT01282203
Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevorane in Adult Patients Requiring General Anesthesia for Surgery in Terms of Quality of Anesthesia and Its Influence on the Cardiovascular System in Common Clinical Practice
NCT01282086
Effects of Sevoflurane vs Desflurane on Early Recovery and Cognitive Function in Elderly Patients Undergoing Scheduled Non-Cardiac Surgery
NCT07289945
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sevoflurane
Sevoflurane Based Volatile Induction and Maintenance of Anaesthesia
Sevoflurane
Induction of anesthesia: fentanyl 2 µg kg-1 and a bolus inhalation of 8% sevoflurane in an 8 L.min-1 fresh gas flow. Anesthesia maintenance: 1 minimal alveolar concentration (MAC) sevoflurane at a low fresh gas flow of 0.6-0.8 L min-1 in a 60% air-oxygen mixture supplemented with boluses of fentanyl.
Propofol
Propofol Based Total Intravenous Anesthesia
Propofol
Induction of anesthesia: propofol 2 mg kg-1 and fentanyl 4 µg kg-1. Maintenance of anesthesia: infusion of propofol 8 mg kg-1 h-1 and boluses of fentanyl 3 µg kg-1.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sevoflurane
Induction of anesthesia: fentanyl 2 µg kg-1 and a bolus inhalation of 8% sevoflurane in an 8 L.min-1 fresh gas flow. Anesthesia maintenance: 1 minimal alveolar concentration (MAC) sevoflurane at a low fresh gas flow of 0.6-0.8 L min-1 in a 60% air-oxygen mixture supplemented with boluses of fentanyl.
Propofol
Induction of anesthesia: propofol 2 mg kg-1 and fentanyl 4 µg kg-1. Maintenance of anesthesia: infusion of propofol 8 mg kg-1 h-1 and boluses of fentanyl 3 µg kg-1.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* history of arterial vascular disease (arterial hypertension, myocardial ischemia and/or cerebral vascular disease)
* undergoing elective non-cardiac surgery (hemicolectomy, hernioplasty, laparoscopic cholecystectomy and laparoscopic hysterectomy)
Exclusion Criteria
* stroke or myocardial infarction ≤ 6 months before surgery
* oncological disease of T2-4N3M1 stage
65 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Negovsky Reanimatology Research Institute
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Valery V. Likhvantsev, MD, Prof.
Role: STUDY_CHAIR
Negovsky Reanimatology Research Institute, Moscow, Russia
Oleg A. Grebenchikov, MD, PhD
Role: STUDY_DIRECTOR
Negovsky Reanimatology Research Institute, Moscow, Russia
Yuri V. Iljin
Role: PRINCIPAL_INVESTIGATOR
Negovsky Reanimatology Research Institute, Moscow, Russia
Alexander V. Mironenko, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Negovsky Reanimatology Research Institute, Moscow, Russia
Yuri V. Skripkin
Role: PRINCIPAL_INVESTIGATOR
Negovsky Reanimatology Research Institute, Moscow, Russia
Dmitriy B. Selivanov, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital Maria Vittoria, Turin, Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical center of the Main Administration for Service to the Diplomatic Corps
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
s100b
Identifier Type: OTHER
Identifier Source: secondary_id
Sev003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.